{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:48:28Z","timestamp":1775152108967,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10072-024-07410-1","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T13:02:03Z","timestamp":1708779723000},"page":"3853-3859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of leuprorelin in spinal and bulbar muscular atrophy: a 3-year observational study"],"prefix":"10.1007","volume":"45","author":[{"given":"Min-Gu","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Sun","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-9206","authenticated-orcid":false,"given":"Jin-Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,24]]},"reference":[{"key":"7410_CR1","doi-asserted-by":"publisher","unstructured":"Bosch E (2017) Spinal and bulbar muscular atrophy (Kennedy Disease). Neurodegeneration 202\u2013210. https:\/\/doi.org\/10.1002\/9781118661895.ch17","DOI":"10.1002\/9781118661895.ch17"},{"key":"7410_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2006.01.021","volume":"200","author":"M Katsuno","year":"2006","unstructured":"Katsuno M, Adachi H, Waza M et al (2006) Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol 200:8\u201318","journal-title":"Exp Neurol"},{"key":"7410_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"ARL Spada","year":"1991","unstructured":"Spada ARL, Wilson EM, Lubahn DB, Harding A, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77\u201379","journal-title":"Nature"},{"key":"7410_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1212\/WNL.50.3.583","volume":"50","author":"WR Kennedy","year":"1998","unstructured":"Kennedy WR, Alter M, Sung JH (1998) Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 50:583\u2013583","journal-title":"Neurology"},{"key":"7410_CR5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/brain\/awac198","volume":"146","author":"HJ Cho","year":"2023","unstructured":"Cho HJ, Shin JH, Park YE et al (2023) Characteristics of spinal and bulbar muscular atrophy in South Korea: a cross-sectional study of 157 patients. Brain 146:1083\u20131092","journal-title":"Brain"},{"key":"7410_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0960-8966(99)00132-7","volume":"10","author":"C Mariotti","year":"2000","unstructured":"Mariotti C, Castellotti B, Pareyson D et al (2000) Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord 10:391\u2013397","journal-title":"Neuromuscul Disord"},{"key":"7410_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0022-510X(93)90157-T","volume":"117","author":"G Sobue","year":"1993","unstructured":"Sobue G, Doyu M, Kachi T et al (1993) Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J Neurol Sci 117:74\u201378","journal-title":"J Neurol Sci"},{"key":"7410_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL (2002) Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59:770\u2013772","journal-title":"Neurology"},{"key":"7410_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K et al (2009) Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65:140\u2013150","journal-title":"Ann Neurol"},{"key":"7410_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, Banno H, Suzuki K et al (2010) Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:875\u2013884","journal-title":"Lancet Neurol"},{"key":"7410_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno M, Adachi H, Doyu M et al (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9:768\u2013773","journal-title":"Nat Med"},{"issue":"9","key":"7410_CR12","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1007\/s00415-021-10503-y","volume":"268","author":"Kang Dae-Won Min-Gu","year":"2021","unstructured":"Min-Gu Kang Dae-Won, Hee-Jin Gwak, Yu-Sun Cho, Jin-Sung Min, Park, (2021) Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year. J Neurol 268(9):3344\u20133351","journal-title":"J Neurol"},{"key":"7410_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2165\/00003495-199448060-00008","volume":"48","author":"GL Plosker","year":"1994","unstructured":"Plosker GL, Brogden RN (1994) Leuprorelin. Drugs 48:930\u2013967","journal-title":"Drugs"},{"key":"7410_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000474238","volume":"30","author":"H Wechsel","year":"1996","unstructured":"Wechsel H, Zerbib M, Pagano F, Coptcoat M (1996) Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer. Eur Urol 30:7\u201314","journal-title":"Eur Urol"},{"key":"7410_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3988\/jcn.2020.16.4.586","volume":"16","author":"SI Oh","year":"2020","unstructured":"Oh SI, Oh J, Park D, Son K, Park JS (2020) Reliability and validity of the Korean version of the spinal and bulbar muscular atrophy functional rating scale. J Clin Neurol 16:586\u2013591","journal-title":"J Clin Neurol"},{"key":"7410_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13\u201321","journal-title":"J Neurol Sci"},{"key":"7410_CR17","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1212\/01.wnl.0000312510.49768.eb","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin N, Klein C, Mandrekar J, Sorenson E (2008) Natural history of spinal-bulbar muscular atrophy. Neurology 70:1967\u20131971","journal-title":"Neurology"},{"key":"7410_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/mus.21077","volume":"38","author":"Y Takeuchi","year":"2008","unstructured":"Takeuchi Y, Katsuno M, Banno H et al (2008) Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 38:964\u2013971","journal-title":"Muscle Nerve"},{"issue":"1","key":"7410_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee","year":"2002","unstructured":"Committee ATS, on Proficiency Standards for Clinical Pulmonary Function Laboratories, (2002) ATS statement on six-minute walk test. Am J Respir Crit Care Med 166(1):111\u2013117. https:\/\/doi.org\/10.1164\/ajrccm.166.1.at1102","journal-title":"Am J Respir Crit Care Med"},{"key":"7410_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2012.25","volume":"16","author":"N Shore","year":"2013","unstructured":"Shore N, Abrahamsson P-A, Anderson J, Crawford E, Lange P (2013) New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists. Prostate Cancer Prostatic Dis 16:7","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"7410_CR21","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1200\/JCO.2006.08.8534","volume":"25","author":"P Schmid","year":"2007","unstructured":"Schmid P, Untch M, Koss\u00e9 V et al (2007) Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study. J Clin Oncol 25:2509\u20132515","journal-title":"J Clin Oncol"},{"key":"7410_CR22","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1517\/13543784.16.11.1851","volume":"16","author":"AC Wilson","year":"2007","unstructured":"Wilson AC, VadakkadathMeethal S, Bowen RL, Atwood CS (2007) Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs 16:1851\u20131863","journal-title":"Expert Opin Investig Drugs"},{"key":"7410_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00002512-199101060-00008","volume":"1","author":"P Chrisp","year":"1991","unstructured":"Chrisp P, Sorkin EM (1991) Leuprorelin. Drugs Aging 1:487\u2013509","journal-title":"Drugs Aging"},{"key":"7410_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1440-1789.2009.01013.x","volume":"29","author":"K Suzuki","year":"2009","unstructured":"Suzuki K, Kastuno M, Banno H, Sobue G (2009) Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA). Neuropathology 29:509\u2013516","journal-title":"Neuropathology"},{"key":"7410_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/jnnp-2017-316015","volume":"88","author":"A Hashizume","year":"2017","unstructured":"Hashizume A, Katsuno M, Suzuki K et al (2017) Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. J Neurol Neurosurg Psychiatry 88:1026\u20131032","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07410-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07410-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07410-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T04:09:04Z","timestamp":1721189344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07410-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7410"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07410-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,24]]},"assertion":[{"value":"17 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Kyungpook National University Chilgok Hospital (KNUCH 2018\u201301-009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}